Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 60 holding rows worth $357,322,000.

Accession
0001493152-17-009004
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 60 entries on the cover page, a total value of $357,322,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $357,322,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS365,000$51,436,000thousands by filing dateput
SPDR SER TR78464A870S&P BIOTECH382,300$29,506,000thousands by filing dateput
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR924,483$25,664,000thousands by filing date
VERACYTE INC COM92337F107Stock3,080,145$25,658,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM3,415,044$25,101,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM1,030,072$21,271,000thousands by filing date
IRIDEX CORP462684101COM1,737,540$17,184,000thousands by filing date
EDGE THERAPEUTICS INC279870109COM1,504,612$15,437,000thousands by filing date
IMMUNOMEDICS INC452907108COM1,600,000$14,128,000thousands by filing date
NABRIVA THERAPEUTICS PLCG63637105SHS945,737$9,911,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM1,358,351$8,218,000thousands by filing date
KITE PHARMA INC49803L109COM75,000$7,775,000thousands by filing date
EVOLENT HEALTH INC CL A30050B101Stock280,600$7,113,000thousands by filing date
RA PHARMACEUTICALS INC74933V108COM373,507$7,000,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM250,000$6,973,000thousands by filing date
CAS MED SYS INC124769209COM4,760,151$5,522,000thousands by filing date
Johnson & Johnson478160104COM40,000$5,292,000thousands by filing dateput
VIVEVE MED INC92852W204COM NEW710,000$5,098,000thousands by filing date
Viewra, Inc92672L107COM686,387$4,441,000thousands by filing date
ZOGENIX INC.98978L204Common Stock301,700$4,375,000thousands by filing date
QUOTIENT LTDG73268107SHS551,196$4,057,000thousands by filing date
ANAPTYSBIO INC032724106COM165,690$3,965,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR107,765$3,848,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM185,000$3,820,000thousands by filing datecall
TESARO INC881569107COM23,700$3,315,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR152,837$3,242,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock90,000$2,441,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM80,000$2,391,000thousands by filing dateput
IOVANCE BIOTHERAPEUTICS INC462260100COM324,000$2,381,000thousands by filing datecall
INTEC PHARMA LTD JERUSALEMM53644106SHS400,000$2,280,000thousands by filing date
NEURODERM LTDM74231107ORD SHS72,866$2,179,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM40,000$2,102,000thousands by filing dateput
WEBMD HEALTH CORP94770V102COM33,000$1,935,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM20,000$1,873,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM89,600$1,828,000thousands by filing dateput
EXELIXIS INC COM30161Q104Stock70,000$1,724,000thousands by filing dateput
SPECTRANETICS CORP84760C107COM40,000$1,536,000thousands by filing dateput
ZOGENIX INC.98978L204Common Stock100,000$1,450,000thousands by filing dateput
SOCIETAL CDMO INC75629F109COM200,500$1,410,000thousands by filing date
ALIMERA SCIENCES INC016259103COM974,318$1,354,000thousands by filing date
VERACYTE INC COM92337F107Stock160,000$1,333,000thousands by filing datecall
GLAUKOS CORP COM377322102Stock24,100$999,000thousands by filing dateput
INVITAE CORP46185L103COM100,292$959,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock168,685$938,000thousands by filing date
ZIOPHARM ONCOLOGY INC98973P101COM150,000$933,000thousands by filing dateput
INSMED INC COM PAR $.01457669307Stock50,000$858,000thousands by filing dateput
VERSARTIS INC92529L102COM49,100$857,000thousands by filing dateput
OMEROS CORP682143102COM40,000$796,000thousands by filing dateput
ACORDA THERAPEUTICS INC00484M106COM30,000$591,000thousands by filing dateput
GOGO INC38046C109COM50,000$577,000thousands by filing dateput
MYRIAD GENETICS INC62855J104COM19,400$501,000thousands by filing dateput
CYTOKINETICS INC23282W605COM NEW40,000$484,000thousands by filing dateput
IMMUNOGEN INC45253H101COMMON STOCK50,000$356,000thousands by filing datecall
NEURODERM LTDM74231107ORD SHS10,000$299,000thousands by filing dateput
SANGAMO THERAPEUTICS INC800677106COM30,000$264,000thousands by filing dateput
ESSA PHARMA INC29668H104COM442,000$242,000thousands by filing date
MANNKIND CORP COM NEW56400P706Stock32,300$46,000thousands by filing dateput
ONCOBIOLOGICS INC68235M105COM29,082$29,000thousands by filing date
ONCOBIOLOG-CW17A68235M113EQUITY WRT96,833$17,000thousands by filing date
ONCOBIOLOGICS INC68235M121*W EXP 05/18/20196,833$9,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-17-009004this filing2017-08-14acceptance time not in the bulk data set